Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry

Author： Beumer J.   Garner R.   Cohen M.   Galbraith S.   Duncan G.   Griffin T.   Beijnen J.   Schellens J.  

Publisher： Springer Publishing Company

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.25, Iss.4, 2007-08, pp. : 327-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Combined Accelerator Mass Spectrometry-Positron Emission Tomography Human Microdose Study with 14C- and 11C-Labelled Verapamil

By Wagner Claudia C.  

Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. : 111-120

Adis International

Access to resources Recommend Favorite

The use of accelerator mass spectrometry to obtain early human ADME/PK data

By Lappin Graham   Garner R Colin  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite

Bioanalytical Applications of Accelerator Mass Spectrometry for Pharmaceutical Research

By  

Current Pharmaceutical Design, Vol. 6, Iss. 10, 2000-07 ,pp. : 991-1007

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Liquid Chromatography-Accelerator Mass Spectrometry (LC-AMS) to Evaluate the Metabolic Profiles of a Drug Candidate in Human Urine and Plasma

By  

Drug Metabolism Letters, Vol. 1, Iss. 3, 2007-08 ,pp. : 226-231

Bentham Science Publishers

Access to resources Recommend Favorite

Mass Balance Studies, with a Focus on Anticancer Drugs

By Beumer Jan H.   Beijnen Jos H.   Schellens Jan H.M.  

Clinical Pharmacokinetics, Vol. 45, Iss. 1, 2006-01 ,pp. : 33-58

Adis International

Access to resources Recommend Favorite